Refractory Hodgkin Lymphoma
Showing 26 - 27 of 27
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte, New York (brentuximab vedotin)
Completed
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- brentuximab vedotin
-
Duarte, California
- +1 more
Mar 28, 2018
Refractory Hodgkin Lymphoma, Recurrent Adult Hodgkin's Lymphoma Trial (INCB040093 Monotherapy, INCB040093, itacitinib)
Terminated
- Refractory Hodgkin Lymphoma
- Recurrent Adult Hodgkin's Lymphoma
- INCB040093 Monotherapy
- +2 more
- (no location specified)
Jan 8, 2018